LYBLyondellBasell
$60.73+41% 1Y
$60.73
$40.2852 weeks$81.53
The business
How LYB's business earns
LyondellBasell earns 12% on the capital it employs against an estimated 9.0% cost of capital.
12%
Return on invested capital · cost of capital 9.0% · 2.9 points above the estimated cost of capital
- Operating margin
- 8.6%
Operating margin · Specialty Chemicals median 8.6% · 12 months to Sep 30, 2026
- Cash conversion
- 1.75×
Cash conversion · operating cash flow divided by operating profit after tax
- R&D as % of revenue
- 0.43%
R&D as % of revenue
Operating margin by fiscal year
| Year | Operating margin |
|---|---|
| FY2020 | 5.6% |
| FY2021 | 15% |
| FY2022 | 10% |
| FY2023 | 8.2% |
| FY2024 | 5.7% |
| FY2025 | −1.4% |
Details›
- Gross margin12 months to Sep 30, 2026
- 14%
- Operating margin12 months to Sep 30, 2026
- 8.6%
- Net margin12 months to Sep 30, 2026
- 4.1%
- Free cash flow margin
- 7.5%
- R&D as % of revenue
- 0.43%
- Revenue, trailing twelve months
- $32.0B
- Free cash flow, trailing twelve months
- $2.41B
- Net income, trailing twelve months
- $1.30B
- Return on invested capitaloperating profit after tax ÷ debt + equity − cash
- 12%
Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.
Specialty Chemicals
The closest names by size in the same industry